Drug Information

Drug General Information
Drug ID
D02VMJ
Former ID
DNC010893
Drug Name
TRICLABENDAZOLE
Drug Type
Small molecular drug
Indication Helminth infection [ICD9: 001-139; ICD10:A00-B99] Approved [551871]
Structure
Download
2D MOL

3D MOL
Formula
C14H9Cl3N2OS
Canonical SMILES
CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl
InChI
1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)
InChIKey
NQPDXQQQCQDHHW-UHFFFAOYSA-N
CAS Number
CAS 68786-66-3
PubChem Compound ID
50248
SuperDrug ATC ID
P02BX04
Target and Pathway
Target(s) Cruzipain Target Info Inhibitor [530877]
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 530877J Med Chem. 2010 May 27;53(10):4259-65.Colloid formation by drugs in simulated intestinal fluid.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.